Sanofi

Insider Reports History

Entity
Company
Location
46 Avenue De La Grande Armee, Paris, France
Signature
/s/ Alexandra Roger, Alexandra Roger, Head of Legal Corporate & Finance
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanofi:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Translate Bio, Inc. 10%+ Owner Common Stock, par value $0.001 per share 75.7M $2.88B $38.00 Sep 14, 2021 Direct
MeiraGTx Holdings plc 10%+ Owner Ordinary Shares ($0.00003881 par value per share) 11.5M $73.1M $6.36 Aug 12, 2024 Through its wholly-owned subsidiary, Sanofi Foreign Participations B.V.
Icosavax, Inc. 10%+ Owner Common Stock (par value, $0.0001) 3.16M $49.4M $15.67 Aug 2, 2021 Through its wholly-owned subsidiary, Aventis Inc.
MeiraGTx Holdings plc 10%+ Owner Ordinary Shares ($0.00003881 par value per share) 698K $4.44M $6.36 Aug 12, 2024 Through its wholly-owned subsidiary Kadmon Corporation, LLC
Icosavax, Inc. 10%+ Owner Series A-1 Preferred Stock (par value, $0.0001) 0 Aug 2, 2021 Through its wholly-owned subsidiary, Aventis Inc
Icosavax, Inc. 10%+ Owner Series B-1 Preferred Stock (par value, $0.0001) 0 Aug 2, 2021 Through its wholly-owned subsidiary, Aventis Inc

Insider Reports Filed by Sanofi

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGTX MeiraGTx Holdings plc Aug 12, 2024 0 $0 3 Aug 13, 2024 10%+ Owner
TBIO Translate Bio, Inc. Sep 14, 2021 2 $2.74B 4 Sep 14, 2021 10%+ Owner
TBIO Translate Bio, Inc. Aug 2, 2021 0 $0 3 Aug 12, 2021 Other*
ICVX Icosavax, Inc. Aug 2, 2021 4 $1M 4 Aug 2, 2021 10%+ Owner
ICVX Icosavax, Inc. Jul 28, 2021 0 $0 3 Jul 28, 2021 10%+ Owner